Arvinas, Inc. (ARVN)
NASDAQ: ARVN · Real-Time Price · USD
7.41
-0.02 (-0.27%)
At close: Oct 2, 2026, 4:00 PM EDT
7.28
-0.13 (-1.75%)
After-hours: Oct 2, 2026, 7:30 PM EDT
Arvinas Market Cap
Arvinas has a market cap or net worth of $484.51 million as of October 2, 2026. Its market cap has decreased by -27.72% in one year.
Market Cap
484.51M
Enterprise Value
-75.39M
1-Year Change
-27.72%
Ranking
Category
Stock Price
$7.41
ChartMarket Cap Chart
Since September 27, 2018, Arvinas's market cap has decreased from $500.50M to $484.51M, a decrease of -3.19%. That is a compound annual growth rate of -0.40%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 484.50M | -36.39% |
| Dec 31, 2025 | 761.70M | -42.17% |
| Dec 31, 2024 | 1.32B | -41.84% |
| Dec 29, 2023 | 2.26B | 24.38% |
| Dec 30, 2022 | 1.82B | -58.07% |
| Dec 31, 2021 | 4.34B | 26.11% |
| Dec 31, 2020 | 3.44B | 148.34% |
| Dec 31, 2019 | 1.39B | 233.58% |
| Dec 31, 2018 | 415.70M | -16.94% |
| Sep 27, 2018 | 500.50M | - |
View and export this data all the way back to 2018. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eupraxia Pharmaceuticals | 517.54M |
| Neurogene | 515.09M |
| ProKidney | 504.88M |
| Puma Biotechnology | 503.81M |
| Entera Bio | 497.78M |
| Contineum Therapeutics | 492.84M |
| REGENXBIO | 491.14M |
| Bright Minds Biosciences | 491.05M |